FDA Approves Roflumilast Foam for Scalp, Body Psoriasis ...Middle East

News by : (Medscape) -
The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Roflumilast Foam for Scalp, Body Psoriasis )

Also on site :

Most Viewed News
جديد الاخبار